Stellate Ganglion Block for Major Depressive Disorder.

Clinical trial NCT04727229 · COMPLETED

Trial details

NCT number: NCT04727229
Sponsor: Unity Health Toronto
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Treatment Resistant Depression Major Depressive Disorder

Start date: 2021-09-23
Primary completion: 2022-02-10
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.